24th June, 2010
Innovative Solutions for Managing and Analyzing Local Laboratory Data in Clinical Trials
4th May, 2010
Implications of the FDA’s Updated Definitions for Standardized Data Collection for Cardiovascular Trials
24th March, 2010
Glucose Clamp Techniques for Advancing the Development of Diabetes Type I and Type II Therapeutic Agents
9th February, 2010
Explore the Implications of the Cardiorenal Panel meeting on Statin Drugs
9th December, 2009
Politics, Regulators & Clinical Research
9th September, 2009
Heart Failure Endpoints
19th May, 2009
Cardiovascular Outcomes – Studies in type 2 Diabetes: Practical Solutions to Current Challenges
25th February, 2009
Introduction to the Thorough QT Study: Why and How?
13th November, 2008
DSMBs, Endpoint Committees, and Adaptive Trials: Synergy, Technology and Innovation
11th September, 2008
Qualified Person for Pharmacovigilance (QPPV): Roles and Responsibilities
28th May, 2008
Drug Safety Reporting, Regulations, and Risk: What is Required Today and Where Will We Be Tomorrow?